Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.

Golshan M, Loibl S, Wong SM, Houber JB, O'Shaughnessy J, Rugo HS, Wolmark N, McKee MD, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE Jr, Sikov WM, Untch M.

JAMA Surg. 2020 Jan 8:e195410. doi: 10.1001/jamasurg.2019.5410. [Epub ahead of print]

PMID:
31913413
2.

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Fehrenbacher L, Cecchini RS, Geyer CE Jr, Rastogi P, Costantino JP, Atkins JN, Crown JP, Polikoff J, Boileau JF, Provencher L, Stokoe C, Moore TD, Robidoux A, Flynn PJ, Borges VF, Albain KS, Swain SM, Paik S, Mamounas EP, Wolmark N.

J Clin Oncol. 2020 Feb 10;38(5):444-453. doi: 10.1200/JCO.19.01455. Epub 2019 Dec 10.

PMID:
31821109
3.

Targeting Endothelin Receptors in a Murine Model of Myocardial Infarction Using a Small Molecular Fluorescent Probe.

Kimm MA, Haas H, Stölting M, Kuhlmann M, Geyer C, Glasl S, Schäfers M, Ntziachristos V, Wildgruber M, Höltke C.

Mol Pharm. 2020 Jan 6;17(1):109-117. doi: 10.1021/acs.molpharmaceut.9b00810. Epub 2019 Dec 18.

PMID:
31816245
4.

A new translation and reader's guide to Victor von Ebner's classical description of spermatogenesis.

Jones SL, Harris K, Geyer CB.

Mol Reprod Dev. 2019 Nov;86(11):1462-1484. doi: 10.1002/mrd.23282. Epub 2019 Oct 22. Review.

PMID:
31642147
5.

Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.

Golshan M, Wong SM, Loibl S, Huober JB, O'Shaughnessy J, Rugo HS, Wolmark N, Ansell P, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE Jr, Sikov WM, Untch M.

Eur J Surg Oncol. 2020 Feb;46(2):223-228. doi: 10.1016/j.ejso.2019.10.002. Epub 2019 Oct 5.

PMID:
31606288
6.

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

Sparano JA, Gray RJ, Makower DF, Albain KS, Saphner TJ, Badve SS, Wagner LI, Kaklamani VG, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Toppmeyer DL, Brufsky AM, Goetz MP, Berenberg JL, Mahalcioiu C, Desbiens C, Hayes DF, Dees EC, Geyer CE Jr, Olson JA Jr, Wood WC, Lively T, Paik S, Ellis MJ, Abrams J, Sledge GW Jr.

JAMA Oncol. 2019 Sep 30. doi: 10.1001/jamaoncol.2019.4794. [Epub ahead of print]

PMID:
31566680
7.

111In- and 225Ac-Labeled Cixutumumab for Imaging and α-Particle Radiotherapy of IGF-1R Positive Triple-Negative Breast Cancer.

Solomon VR, Alizadeh E, Bernhard W, Hartimath SV, Hill W, Chekol R, Barreto KM, Geyer CR, Fonge H.

Mol Pharm. 2019 Nov 5. doi: 10.1021/acs.molpharmaceut.9b00542. [Epub ahead of print]

PMID:
31518138
8.

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.

Swain SM, Tang G, Lucas PC, Robidoux A, Goerlitz D, Harris BT, Bandos H, Geyer CE Jr, Rastogi P, Mamounas EP, Wolmark N.

Breast Cancer Res Treat. 2019 Nov;178(2):389-399. doi: 10.1007/s10549-019-05398-3. Epub 2019 Aug 19.

9.

Acyl-CoA synthetase 6 enriches seminiferous tubules with the ω-3 fatty acid docosahexaenoic acid and is required for male fertility in the mouse.

Hale BJ, Fernandez RF, Kim SQ, Diaz VD, Jackson SN, Liu L, Brenna JT, Hermann BP, Geyer CB, Ellis JM.

J Biol Chem. 2019 Sep 27;294(39):14394-14405. doi: 10.1074/jbc.RA119.009972. Epub 2019 Aug 9.

PMID:
31399511
10.

A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51.

Pastushok L, Fu Y, Lin L, Luo Y, DeCoteau JF, Lee K, Geyer CR.

Sci Rep. 2019 Aug 2;9(1):11227. doi: 10.1038/s41598-019-47600-y.

11.

PRISER: Managing Notification in Multiples Devices with Data Privacy Support.

Silva LA, Leithardt VRQ, Rolim CO, González GV, Geyer CFR, Silva JS.

Sensors (Basel). 2019 Jul 13;19(14). pii: E3098. doi: 10.3390/s19143098.

12.

Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?

Ross M, Geyer CE Jr.

J Clin Oncol. 2019 Sep 1;37(25):2196-2200. doi: 10.1200/JCO.19.00877. Epub 2019 Jul 15. No abstract available.

PMID:
31306044
13.

The Complex Interplay Between Weight, Chronic Pain, and Mood: How Team-Based Care and Personalized Approaches Can Improve Function and Quality of Life.

Geyer C.

Am J Lifestyle Med. 2019 Apr 23;13(4):362-366. doi: 10.1177/1559827619840638. eCollection 2019 Jul-Aug.

PMID:
31285718
14.

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2019 Jun 20;380(25):2395-2405. doi: 10.1056/NEJMoa1904819. Epub 2019 Jun 3.

15.

Endoscopic ultrasound-guided injection of N-butyl-2-cyanoacrylate into portal venous collateral vessels that were feeding bleeding duodenal varices.

Wallstabe I, Zurek M, Geyer C.

Endoscopy. 2019 Oct;51(10):E293-E294. doi: 10.1055/a-0915-1424. Epub 2019 May 23. No abstract available.

PMID:
31121625
16.

Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.

Helfen A, Große Hokamp N, Geyer C, Heindel W, Bremer C, Vogl T, Höltke C, Masthoff M, Barczyk-Kahlert K, Roth J, Wildgruber M, Eisenblaetter M.

Mol Imaging Biol. 2020 Feb;22(1):66-72. doi: 10.1007/s11307-019-01370-1.

PMID:
31098983
17.

Differential RA responsiveness directs formation of functionally distinct spermatogonial populations at the initiation of spermatogenesis in the mouse.

Velte EK, Niedenberger BA, Serra ND, Singh A, Roa-DeLaCruz L, Hermann BP, Geyer CB.

Development. 2019 May 13;146(12). pii: dev173088. doi: 10.1242/dev.173088.

18.

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.

Kim RS, Song N, Gavin PG, Salgado R, Bandos H, Kos Z, Floris G, Eynden GGGMVD, Badve S, Demaria S, Rastogi P, Fehrenbacher L, Mamounas EP, Swain SM, Wickerham DL, Costantino JP, Paik S, Wolmark N, Geyer CE, Lucas PC, Pogue-Geile KL.

J Natl Cancer Inst. 2019 Aug 1;111(8):867-871. doi: 10.1093/jnci/djz032.

PMID:
30888406
19.

Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments.

Bernhard W, El-Sayed A, Barreto K, Gonzalez C, Fonge H, Geyer CR.

Theranostics. 2019 Jan 30;9(4):974-985. doi: 10.7150/thno.30835. eCollection 2019.

20.

Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs.

Barreto K, Maruthachalam BV, Hill W, Hogan D, Sutherland AR, Kusalik A, Fonge H, DeCoteau JF, Geyer CR.

Nucleic Acids Res. 2019 May 21;47(9):e50. doi: 10.1093/nar/gkz131.

21.

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft.

Hartimath SV, El-Sayed A, Makhlouf A, Bernhard W, Gonzalez C, Hill W, Parada AC, Barreto K, Geyer CR, Fonge H.

Oncotarget. 2019 Feb 1;10(10):1031-1044. doi: 10.18632/oncotarget.26613. eCollection 2019 Feb 1.

22.

Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models.

Hartimath SV, Alizadeh E, Solomon VR, Chekol R, Bernhard W, Hill W, Parada AC, Barreto K, Geyer CR, Fonge H.

J Nucl Med. 2019 Aug;60(8):1103-1110. doi: 10.2967/jnumed.118.220095. Epub 2019 Jan 17.

PMID:
30655327
23.

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators.

N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5.

PMID:
30516102
24.

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.

Mamounas EP, Bandos H, Lembersky BC, Jeong JH, Geyer CE Jr, Rastogi P, Fehrenbacher L, Graham ML, Chia SK, Brufsky AM, Walshe JM, Soori GS, Dakhil SR, Seay TE, Wade JL 3rd, McCarron EC, Paik S, Swain SM, Wickerham DL, Wolmark N.

Lancet Oncol. 2019 Jan;20(1):88-99. doi: 10.1016/S1470-2045(18)30621-1. Epub 2018 Nov 30. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

25.

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.

Geyer CE Jr, Tang G, Mamounas EP, Rastogi P, Paik S, Shak S, Baehner FL, Crager M, Wickerham DL, Costantino JP, Wolmark N.

NPJ Breast Cancer. 2018 Nov 14;4:37. doi: 10.1038/s41523-018-0090-6. eCollection 2018.

26.

The Mammalian Spermatogenesis Single-Cell Transcriptome, from Spermatogonial Stem Cells to Spermatids.

Hermann BP, Cheng K, Singh A, Roa-De La Cruz L, Mutoji KN, Chen IC, Gildersleeve H, Lehle JD, Mayo M, Westernströer B, Law NC, Oatley MJ, Velte EK, Niedenberger BA, Fritze D, Silber S, Geyer CB, Oatley JM, McCarrey JR.

Cell Rep. 2018 Nov 6;25(6):1650-1667.e8. doi: 10.1016/j.celrep.2018.10.026.

27.

Post-translational Assembly of Protein Parts into Complex Devices by Using SpyTag/SpyCatcher Protein Ligase.

Sutherland AR, Alam MK, Geyer CR.

Chembiochem. 2019 Feb 1;20(3):319-328. doi: 10.1002/cbic.201800538. Epub 2018 Dec 6. Review.

PMID:
30358052
28.

In Search of a Good Night's Sleep: Hormones, Mind, Movement, and Breath.

Geyer C.

Am J Lifestyle Med. 2017 Dec 28;12(2):120-123. doi: 10.1177/1559827617747222. eCollection 2018 Mar-Apr.

29.

Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.

El-Sayed A, Bernhard W, Barreto K, Gonzalez C, Hill W, Pastushok L, Fonge H, Geyer CR.

Theranostics. 2018 Sep 9;8(17):4856-4869. doi: 10.7150/thno.24252. eCollection 2018.

30.

The mTORC1 component RPTOR is required for maintenance of the foundational spermatogonial stem cell pool in mice†.

Serra N, Velte EK, Niedenberger BA, Kirsanov O, Geyer CB.

Biol Reprod. 2019 Feb 1;100(2):429-439. doi: 10.1093/biolre/ioy198.

31.

Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive.

Keszei M, Record J, Kritikou JS, Wurzer H, Geyer C, Thiemann M, Drescher P, Brauner H, Köcher L, James J, He M, Baptista MA, Dahlberg CI, Biswas A, Lain S, Lane DP, Song W, Pütsep K, Vandenberghe P, Snapper SB, Westerberg LS.

J Clin Invest. 2018 Aug 31;128(9):4115-4131. doi: 10.1172/JCI64772. Epub 2018 Aug 20.

32.

99mTc(CO)3+ labeled domain I/II-specific anti-EGFR (scFv)2 antibody fragment for imaging EGFR expression.

Solomon VR, Gonzalez C, Alizadeh E, Bernhard W, Hartimath SV, Barreto K, Geyer CR, Fonge H.

Eur J Med Chem. 2018 Sep 5;157:437-446. doi: 10.1016/j.ejmech.2018.08.014. Epub 2018 Aug 6.

PMID:
30103192
33.

Publisher's Note: A historical perspective on some "new" discoveries on spermatogenesis from the laboratory of Enrico Sertoli in 1878.

Geyer CB.

Biol Reprod. 2018 Sep 1;99(3):671. doi: 10.1093/biolre/ioy146. No abstract available.

PMID:
30060065
34.

Spatial and temporal variations in the geochemistry of shallow groundwater contaminated with nitrate at a residential site.

Atekwana EA, Geyer CJ.

Environ Sci Pollut Res Int. 2018 Sep;25(27):27155-27172. doi: 10.1007/s11356-018-2714-7. Epub 2018 Jul 19.

PMID:
30022393
35.

Dynamic cytoplasmic projections connect mammalian spermatogonia in vivo.

Niedenberger BA, Cook K, Baena V, Serra ND, Velte EK, Agno JE, Litwa KA, Terasaki M, Hermann BP, Matzuk MM, Geyer CB.

Development. 2018 Aug 13;145(15). pii: dev161323. doi: 10.1242/dev.161323.

36.

Synthetic antigen-binding fragments (Fabs) against S. mutans and S. sobrinus inhibit caries formation.

Alam MK, Zheng L, Liu R, Papagerakis S, Papagerakis P, Geyer CR.

Sci Rep. 2018 Jul 5;8(1):10173. doi: 10.1038/s41598-018-28240-0.

37.

Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.

Alam MK, El-Sayed A, Barreto K, Bernhard W, Fonge H, Geyer CR.

Mol Imaging Biol. 2019 Feb;21(1):54-66. doi: 10.1007/s11307-018-1222-y.

PMID:
29948640
38.

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT and TEXT Investigators and the International Breast Cancer Study Group.

N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4.

39.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.

40.

[WITHDRAWN AS DUPLICATE] A historical perspective on some "new" discoveries on spermatogenesis from the laboratory of Enrico Sertoli in 1878.

Geyer CB.

Biol Reprod. 2018 Sep 1;99(3):E1-E3. doi: 10.1093/biolre/ioy104. No abstract available. Retraction in: Biol Reprod. 2018 Sep 1;99(3):671.

PMID:
29718101
41.

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Toosi BM, El Zawily A, Truitt L, Shannon M, Allonby O, Babu M, DeCoteau J, Mousseau D, Ali M, Freywald T, Gall A, Vizeacoumar FS, Kirzinger MW, Geyer CR, Anderson DH, Kim T, Welm AL, Siegel P, Vizeacoumar FJ, Kusalik A, Freywald A.

Oncogene. 2018 Jul;37(30):4073-4093. doi: 10.1038/s41388-018-0228-x. Epub 2018 Apr 27.

42.

89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I.

Chekol R, Solomon VR, Alizadeh E, Bernhard W, Fisher D, Hill W, Barreto K, DeCoteau JF, Parada AC, Geyer CR, Fonge H.

Oncotarget. 2018 Mar 30;9(24):17117-17132. doi: 10.18632/oncotarget.24965. eCollection 2018 Mar 30.

43.

Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation.

Vogl T, Stratis A, Wixler V, Völler T, Thurainayagam S, Jorch SK, Zenker S, Dreiling A, Chakraborty D, Fröhling M, Paruzel P, Wehmeyer C, Hermann S, Papantonopoulou O, Geyer C, Loser K, Schäfers M, Ludwig S, Stoll M, Leanderson T, Schultze JL, König S, Pap T, Roth J.

J Clin Invest. 2018 May 1;128(5):1852-1866. doi: 10.1172/JCI89867. Epub 2018 Apr 3.

44.

OpenNotes in oncology: oncologists' perceptions and a baseline of the content and style of their clinician notes.

Alpert JM, Morris BB, Thomson MD, Matin K, Geyer CE, Brown RF.

Transl Behav Med. 2019 Mar 1;9(2):347-356. doi: 10.1093/tbm/iby029.

45.

Assessment of MMP-2/-9 expression by fluorescence endoscopy for evaluation of anastomotic healing in a murine model of anastomotic leakage.

Neumann PA, Twardy V, Becker F, Geyer C, Schwegmann K, Mohr A, Faust A, Lenz P, Rijcken E.

PLoS One. 2018 Mar 22;13(3):e0194249. doi: 10.1371/journal.pone.0194249. eCollection 2018.

46.

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.

Loibl S, O'Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, Huober J, Golshan M, von Minckwitz G, Maag D, Sullivan D, Wolmark N, McIntyre K, Ponce Lorenzo JJ, Metzger Filho O, Rastogi P, Symmans WF, Liu X, Geyer CE Jr.

Lancet Oncol. 2018 Apr;19(4):497-509. doi: 10.1016/S1470-2045(18)30111-6. Epub 2018 Feb 28.

PMID:
29501363
47.

Advanced immunostaining approaches to study early male germ cell development.

Niedenberger BA, Geyer CB.

Stem Cell Res. 2018 Mar;27:162-168. doi: 10.1016/j.scr.2018.01.031. Epub 2018 Feb 9.

48.

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab.

Bernhard W, El-Sayed A, Barreto K, Gonzalez C, Hill W, Parada AC, Fonge H, Geyer CR.

Oncotarget. 2017 Dec 21;9(5):6213-6227. doi: 10.18632/oncotarget.23557. eCollection 2018 Jan 19.

49.

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

Wapnir IL, Price KN, Anderson SJ, Robidoux A, Martín M, Nortier JWR, Paterson AHG, Rimawi MF, Láng I, Baena-Cañada JM, Thürlimann B, Mamounas EP, Geyer CE Jr, Gelber S, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S; International Breast Cancer Study Group; NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists' Group; Breast International Group.

J Clin Oncol. 2018 Apr 10;36(11):1073-1079. doi: 10.1200/JCO.2017.76.5719. Epub 2018 Feb 14.

50.

Clinical trials in older, less fit populations: an unmet need?

Geyer CE Jr.

Lancet Oncol. 2018 Mar;19(3):271-272. doi: 10.1016/S1470-2045(18)30084-6. Epub 2018 Feb 9. No abstract available.

PMID:
29433964

Supplemental Content

Support Center